The cholecystokinin analogue, caerulein, does not modulate dopamine release or dopamine-induced locomotor activity in the nucleus accumbens of rat
- 1 January 1984
- journal article
- research article
- Published by Elsevier BV in Neuroscience Letters
- Vol. 44 (1), 77-82
- https://doi.org/10.1016/0304-3940(84)90224-6
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Presynaptic modulation of dopamine-induced locomotor activity by oxotremorine in nucleus accumbens of the ratJournal of Neural Transmission, 1982
- The contrasting effects of neuroleptics on transmitter release from the nucleus accumbens and corpus striatumNeuropharmacology, 1982
- CHOLINERGIC ACTION IN THE NUCLEUS ACCUMBENS: MODULATION OF DOPAMINE AND ACETYLCHOLINE RELEASEBritish Journal of Pharmacology, 1982
- Effects of cholecystokinin octapeptide and its fragments on brain monoamines and plasma corticosteroneNeurochemistry International, 1981
- Antinociceptive effect of centrally administered caerulein and cholecystokinin octapeptide (CCK-8)European Journal of Pharmacology, 1981
- A subpopulation of mesencephalic dopamine neurons projecting to limbic areas contains a cholecystokinin-like peptide: Evidence from immunohistochemistry combined with retrograde tracingNeuroscience, 1980
- Cholecystokinin peptides produce marked reduction of dopamine turnover in discrete areas in the rat brain following intraventricular injectionEuropean Journal of Pharmacology, 1980
- Blockade of amphetamine-induced locomotor activity and stereotypy in rats by spiroperidol but not by an atypical neuroleptic, thioridazineNeuropharmacology, 1980
- Serotoninergic modulation of the dopamine response from the nucleus accumbensJournal of Pharmacy and Pharmacology, 1976
- The actions of caerulein on the smooth muscle of the gastrointestinal tract and the gall bladderBritish Journal of Pharmacology, 1968